2020 Excellence in Oncology Award
Oncology Times is now accepting submissions for the 2020 Excellence in Oncology Award, an exciting contest designed to recognize the wonderful research, dedication, and dramatic impact on patients (and their families) that occur every day in oncology.
To enter, please fill out the entry form and email to Pam.Tarapchak@wolterskluwer.com.
Submissions are due by January 15, 2020
- Published or presented research conducted in the last 12 months
- Research must have a clinical/therapeutic impact (i.e., FDA approval, patient outcomes, etc.)
- Lead researcher (or individual nominating the researcher/team) should summarize the research and its impact, and include a link to the published paper or presentation (in less than 500 words)
The top winner will receive a $500 donation in their name to a charity/foundation of their choosing as well as a cover story highlighting their winning researcher. Additional honorees will receive certificates and recognition in Oncology Times.
NEW THIS YEAR: All entries will receive an exclusive 50% off discount code toward the purchse of DeVita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology, 11th Edition.
Check out the 2019 Excellence in Oncology recipients here:
2019 Excellence in Oncology Winner: Adoptive T-Cell Therapy Safe & Effective for Patients With PML
Kathy Rezvani, MD, PhD, at The University of Texas MD Anderson Cancer Center, and her team have been recognized for a phase II, proof-of-concept study showing that adoptive T-cell therapy is a safe and effective approach to treating progressive multifocal leukoencephalopathy in immunosuppressed patients.
First Runner-Up: Landmark Cervical Cancer Surgery Studies Yield Practice-Changing Results
Lead authors: Pedro Tomas Ramirez, MD, and Alejandro Rauh-Hain, MD, MPH, MD Anderson Cancer Center
Second Runner-Up: Finding a Cure for Children With CNS Neuroblastoma
Lead author: Kim Kramer, MD, Memorial Sloan Kettering Cancer Center
- Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain (Lead Researcher: Hussein A. Tawbi, MD, PhD, MD Anderson Cancer Center)
- Practice Transformation—Early Impact of OCM of Hospital Admissions (Lead Researcher: David M. Waterhouse, MD, MPH, Oncology Hematology Care, Inc.)
- Convection-Enhanced Delivery for Diffuse Instrinic Pontine Glioma: A Single-Centre, Dose-Escalation, Phase 1 Trial (Lead Researcher: Mark M. Souweidane, MD, Weill Cornell Medicine and NewYork-Presbyterian)